MedTrace Logo

Introduction of MMS to Antenatal Care in Bamako, Mali

NCT05312242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 486

Last updated 2023-05-01

No results posted yet for this study

Summary

The aim of this implementation research is to compare how different implementation strategies influence the acceptability and adherence to antenatal supplement use in pregnancy.

Conditions

  • Adherence, Medication

Interventions

DIETARY_SUPPLEMENT

United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) MMS

Introduction of UNIMMAP MMS along with novel counseling strategies to increase acceptability and adherence to prenatal supplementation

DIETARY_SUPPLEMENT

Iron Folic Acid Supplement

Standard of Care Intervention

Sponsors & Collaborators

  • Jhpiego

    collaborator OTHER

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • Center for Vaccine Development - Mali

    collaborator OTHER

  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Kristen M Hurley, PhD · Johns Hopkins Bloomberg School of Public Health

  • Lisa Noguchi, PhD · Jhpiego

  • Samba Sow, MD · Center for Vaccine Development - Mali

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-10
Primary Completion
2023-04-15
Completion
2023-04-15

Countries

  • Mali

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05312242 on ClinicalTrials.gov